@article{92b533dad5594d28b93cb414d88a0857,
title = "Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience",
abstract = "More strokes were observed in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) among patients assigned to darbepoetin alfa. We sought to identify baseline characteristics and postrandomization factors that might explain this association.",
keywords = "Aged, Anemia, Case-Control Studies, Diabetes Mellitus, Type 2, Erythropoietin, Female, Follow-Up Studies, Hematinics, Humans, Incidence, Logistic Models, Male, Middle Aged, Multivariate Analysis, Predictive Value of Tests, Prospective Studies, Renal Insufficiency, Chronic, Risk Factors, Risk Reduction Behavior, Stroke, Treatment Outcome",
author = "Hicham Skali and Hans-Henrik Parving and Parfrey, {Patrick S} and Burdmann, {Emmanuel A} and Lewis, {Eldrin F} and Peter Ivanovich and Keithi-Reddy, {Sai Ram} and McGill, {Janet B} and McMurray, {John J V} and Singh, {Ajay K} and Solomon, {Scott D} and Hajime Uno and Pfeffer, {Marc A} and {TREAT Investigators}",
year = "2011",
doi = "10.1161/CIRCULATIONAHA.111.030411",
language = "English",
volume = "124",
pages = "2903--8",
journal = "Circulation (Baltimore)",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "25",
}